Our Concept

CMTA

Innovation leader in cancer precision medicine
Personalized solutions in healthcare
Targeted therapeutics powered by integrative NGS analysis

For patients and clinicians

Personalizing precision medicine with our CMTA (Comprehensive Molecular Tumor Analysis) and ModCell^TM technologies to optimize therapy for each individual patient

For pharmaceutical companies

Certified NGS analytics and ModCell^TM for pre-clinical studies, virtual clinical trials, biomarker identification, drug development and repositioning

For academic laboratories

Partnership for NGS technologies and systems biology applications